Floatz logo

Dabigatran

Thrombotic Disease

St. Antonius HospitalUNKNOWNPhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Thrombotic Disease cohort.

Asset / SponsorPhaseRating
Rivaroxaban
Shanghai Zhongshan Hospital
Phase 4BBB
Aspirin
China National Center for Cardiovascular Diseases
Phase 4BBB
Apixaban
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BB
WARFARIN
China National Center for Cardiovascular Diseases
Phase 4BB
Enoxaparin
Helsinki University Central Hospital
Phase 4BB

View all 23 →

Same molecule, other indications

Dabigatran is also rated in:

atrial fibrillationActive
BBB
Indicative · Phase 4
79 / 100
View asset →
atrial flutterDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
myocardial infarctionDormant
BB
Indicative · Phase 4
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →